Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population

被引:0
|
作者
Dhakchinamoorthi Krishna Kumar
Deepak Gopal Shewade
Marie-Anne Loriot
Philippe Beaune
Jayaraman Balachander
B. V. Sai Chandran
Chandrasekaran Adithan
机构
[1] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Pharmacology
[2] INSERM UMRS 775,University Paris Sorbonne Cité
[3] Assistance Publique des Hôpitaux de Paris,Department of Biochemistry, Georges Pompidou European Hospital
[4] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiology
[5] Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER),Department of Cardiothoracic and Vascular Surgery
来源
European Journal of Clinical Pharmacology | 2014年 / 70卷
关键词
Warfarin; Genotype; Polymorphisms; Pharmacogenetic algorithm;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:47 / 56
页数:9
相关论文
共 50 条
  • [21] Effect of CYP2C9 and VKORC1 genetic polymorphism on Warfarin dose requirement
    Ashavaid, T. F.
    Ponde, C. K.
    Raghavan, R.
    Kapadia, F. N.
    Shah, S. A.
    Natarajan, S.
    THERAPEUTIC DRUG MONITORING, 2011, 33 (04) : 507 - 508
  • [22] The impact of age and CYP2C9 and VKORC1 variants on stable warfarin dose in the paediatric population
    Vear, Susan I.
    Ayers, Gregory D.
    Van Driest, Sara L.
    Sidonio, Robert F.
    Stein, Charles Michael
    Ho, Richard H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 165 (06) : 832 - 835
  • [24] Effect of CYP2C9 and VKORC1 genetic variations on warfarin dose requirements in Indian patients
    Sripriya Natarajan
    Chandrashekhar K. Ponde
    Rajesh M. Rajani
    Farah Jijina
    Roopkumar Gursahani
    Pradnya P. Dhairyawan
    Tester F. Ashavaid
    Pharmacological Reports, 2013, 65 : 1375 - 1382
  • [25] Evaluation of a warfarin dosing algorithm including CYP2C9, VKORC1, and CYP4F2 polymorphisms and non-genetic determinants for the Iranian population
    Mahvash Farajzadeh-Dehkordi
    Fatemeh Samiee-Rad
    Seyed Saeed Farzam
    Amir Javadi
    Sara Cheraghi
    Dariush Hamedi-Asl
    Babak Rahmani
    Pharmacological Reports, 2023, 75 : 695 - 704
  • [26] Combined CYP2C9, VKORC1 and CYP4F2 frequencies among racial and ethnic groups
    Scott, Stuart A.
    Khasawneh, Rame
    Peter, Inga
    Kornreich, Ruth
    Desnick, Robert J.
    PHARMACOGENOMICS, 2010, 11 (06) : 781 - 791
  • [27] The effect of CYP2C9 and VKORC1 genetic polymorphisms on warfarin dose requirements in a pediatric population
    Taskin, Birce Dilge
    Kula, Serdar
    Ergun, Mehmet Ali
    Altun, Demet
    Olgunturk, Rana
    Tunaoglu, Fatma Sedef
    Oguz, Ayse Deniz
    Gursel, Turkiz
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (10) : 791 - 796
  • [28] A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
    Takeuchi, Fumihiko
    McGinnis, Ralph
    Bourgeois, Stephane
    Barnes, Chris
    Eriksson, Niclas
    Soranzo, Nicole
    Whittaker, Pamela
    Ranganath, Venkatesh
    Kumanduri, Vasudev
    McLaren, William
    Holm, Lennart
    Lindh, Jonatan
    Rane, Anders
    Wadelius, Mia
    Deloukas, Panos
    PLOS GENETICS, 2009, 5 (03):
  • [29] Effect of CYP2C9 and VKORC1 genetic polymorphisms on mean daily maintenance dose of acenocoumarol in South Indian patients
    Kumar, Dhakchinamoorthi Krishna
    Madhan, Sivalingam
    Balachander, Jayaramen
    Chandran, B. V. Sai
    Thamijarassy, Bascarne
    Adithan, Chandrasekaran
    THROMBOSIS RESEARCH, 2013, 131 (04) : 363 - 367
  • [30] Prosthetic valve thrombosis - association of genetic polymorphisms of VKORC1, CYP2C9 and CYP4F2 genes
    Kalpana, S. R.
    Bharath, G.
    Jain, Simran
    Moorthy, Nagaraja
    Manjunath, Satvic C.
    Christopher, Rita
    MEDICINE, 2019, 98 (06)